| ■ 영문 제목 : Oral Clinical Nutrition Market Size, Share & Trends Analysis Report By Stage (Adults, Pediatrics), By Indication (Dysphagia, Alzheimer’s), By Sales Channel, By Region, And Segment Forecasts, 2023 - 2030
|
 | ■ 상품코드 : GRV23MR128
■ 조사/발행회사 : Grand View Research
■ 발행일 : 2023년 2월
■ 페이지수 : 100
■ 작성언어 : 영어
■ 보고서 형태 : PDF
■ 납품 방식 : E메일 (납기:3일)
■ 조사대상 지역 : 세계
■ 산업 분야 : 의료
|
■ 판매가격 / 옵션
(부가세 10% 별도)
| Single User (1인 열람용) | USD5,950 ⇒환산￦8,032,500 | 견적의뢰/주문/질문 |
| Multi User (5인 열람용) | USD6,950 ⇒환산￦9,382,500 | 견적의뢰/주문/질문 |
| Global/corporate License (기업 열람용) | USD8,950 ⇒환산￦12,082,500 | 견적의뢰/구입/질문 |
※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.
|
미국 Grand View Research (그랜드뷰리서치)의 본 조사 보고서는 세계의 경구용 임상 영양 시장 규모가 2023년부터 2030년 사이에 CAGR 5.0% 증가하여, 2030년에는 22,969.4 백만달러에 달할 것으로 전망하고 있습니다. 본 자료는 세계의 경구용 임상 영양 시장을 조사대상으로 하여, 조사 방법 및 범위, 개요, 시장 변동/동향/범위, 스테이지별 (성인, 소아) 분석, 질환별 (알츠하이머병, 연하 장애, 당뇨병, 만성 신장병, 기타) 분석, 판매 채널별 (온라인 판매, 소매 판매, 기관 판매) 분석, 지역별 (북미, 유럽, 아시아 태평양, 중남미, 중동 및 아프리카) 분석, 경쟁 현황 등의 내용을 수록하고 있습니다. 덧붙여 본 리포트는 Abbott Laboratories, Pfizer Inc., Bayer AG, Nestle S.A., GlaxoSmithKline plc, Baxter International Inc., Otsuka Holdings Co., Ltd., Mead Johnson & Company, LLC, Danone Nutricia, Victus, Inc. 와 같은 기업 정보를 포함하고 있습니다.
・조사 방법 및 범위
・개요
・시장 변동/동향/범위
・세계의 경구용 임상 영양 시장 규모 : 스테이지별
- 성인용 경구용 임상 영양의 시장 규모
- 소아용 경구용 임상 영양의 시장 규모
・세계의 경구용 임상 영양 시장 규모 : 질환별
- 알츠하이머병에 사용되는 경구용 임상 영양의 시장 규모
- 연하 장애에 사용되는 경구용 임상 영양의 시장 규모
- 당뇨병에 사용되는 경구용 임상 영양의 시장 규모
- 만성 신장 질환에 사용되는 경구용 임상 영양의 시장 규모
- 기타 질환에 사용되는 경구용 임상 영양의 시장 규모
・세계의 경구용 임상 영양 시장 규모 : 판매 채널별
- 온라인 판매 채널의 시장 규모
- 소매 판매 채널의 시장 규모
- 기관 판매 채널의 시장 규모
・세계의 경구용 임상 영양 시장 규모 : 지역별
- 북미의 경구용 임상 영양 시장 규모
- 유럽의 경구용 임상 영양 시장 규모
- 아시아 태평양의 경구용 임상 영양 시장 규모
- 중남미의 경구용 임상 영양 시장 규모
- 중동과 아프리카의 경구용 임상 영양 시장 규모
・경쟁 현황 |
■ 보고서 개요Oral Clinical Nutrition Market Growth & Trends
The global oral clinical nutrition market is expected to reach USD 22,969.4 million by 2030 and expand at a CAGR of 5.0% for the forecast period 2023-2030, according to a new report by Grand View Research, Inc., Oral clinical nutrition are the supplements such electrolytes, protein, fibre, energy, vitamins and minerals essential for the people with nutrient deficiency. This is due to poor appetite, low food intake and illness. These nutritional products are available in the form of powder, liquid, pudding, fiber, dessert, juices, yogurt and so on which can be consumed orally. They also have a wide range of applications in the treatment of chronic diseases such as cancer, neurological conditions and gastrointestinal disorders.
The key market players are involved in the novel product launch contributing to the global market growth. For instance, in April 2018, Abbott launched a beverage Ensure Protein Max with 2 for people over age 50+ having protein deficiency. The beverage contains 30g protein with 150 calories and 9 amino acids and available in two flavors. The beverage is supplemented with 1g sugar and 22 vitamins and minerals such as Vitamin D, C, and E. Such novel product launch by market players is expected to propel market growth.
Dominant market players are also engaged in collaborations, mergers, acquisitions to enhance the product portfolio and improvise the nutrition portfolio of the company and study the clinical nutrition analysis. This has a positive impact on the global market. For instance, in January 2018, Filament BioSolutions, Inc. entered into a strategic collaboration with CHEO, Ottawa and Ottawa University for a project designed to analyze and study the clinical application of microme-based precision nutrition in IBD. The project was funded by CIHR and Genome Canada.
Moreover, there is rising awareness among people regarding a healthy lifestyle, and consumption of a nutritious diet for improving the body’s immunity and living a healthy and fit life. Along with this, there is a rising prevalence of chronic diseases such as cancer. According to the research, loss of appetite, and malnutrition is observed due to the side effects of the clinical treatment. Due to this, the researchers are engaged in formulating oral clinical nutrition supplements by enhancing their nutritional value to counter the side effects of the clinical treatment. This helps in the overall growth of the market. The government and private organizations are investing and raising funds to cater to the problems of malnutrition by improving the R&D and healthcare sector. For instance, in September 2022, Biden-Harris Administration held a White House Conference on Hunger, Nutrition and Health in America to solve the issues of food and proper diet related to nutrient deficiency due to diseases such as diabetes
, hypertension, and obesity. The conference stated that over USD 4 billion will be invested by the government in the food nutrition industry to improve the nutritional content in the food and promote a healthy living. Such initiative has led to the development of more advanced and effective oral clinical nutrition supplements, which has increased their adoption and growth in the market.
Further, the COVID-19 pandemic has had a positive impact on the oral clinical nutrition market. The demand for oral clinical nutrition supplements has increased catering to the issues faced due to malnutrition. In order to improve the body’s immunity, people have started consuming nutritious food, and supplements enriched with vitamins, fibers, and proteins. Moreover, these supplements are easy to consume. Thus, the global sale of these products has increased in recent years. Market players have also started enhancing the manufacturing capabilities of the food and nutrition departments to cater to the growing demand for quality and regulatory-certified food supplements.
Oral Clinical Nutrition Market Report Highlights
• In 2022, the adult segment held a majority share of the market owing to the increasing incidence of chronic diseases as well as growing awareness about the advantages of clinical nutrition consumed orally to improve health conditions and nutrient deficiency.
• Cancer care segment held the largest share in 2022 owing to its rising prevalence and hospital admissions for cancer treatment.
• Institutional sales held the largest share in 2022. The rise in hospital admissions and a growing number of healthcare facilities such as long-term care centers globally is further driving the segment growth.
• North America held the largest share in 2022 owing to factors such as a large geriatric population, chronic disease burden, and high public & private expenditures on healthcare.
■ 보고서 목차Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.2.1. Information Procurement
1.3. Information or Data Analysis
1.4. Methodology
1.5. Research Scope and Assumptions
1.6. Market Formulation & Validation
1.6.1. Country Market: Cagr Calculation
1.7. Country Based Segment Share Calculation
1.8. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Regional Insights
2.4. Competitive Insights
2.5. Oral Clinical Nutrition Market Snapshot
2.6. Oral Clinical Nutrition Market Segment Snapshot
2.7. Oral Clinical Nutrition Market Competitive Landscape Snapshot
Chapter 3. Oral Clinical Nutrition Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.2.3. Industry Challenge
3.3. Oral Clinical Nutrition Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.1.1. Bargaining power of the suppliers
3.3.1.2. Bargaining power of the buyers
3.3.1.3. Threats of substitution
3.3.1.4. Threats from new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.4. Impact of COVID-19 on Oral Clinical Nutrition Market
Chapter 4. Oral Clinical Nutrition Market: Stage Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Oral Clinical Nutrition Market: Stage Movement Analysis, USD Million, 2022 & 2030
4.3. Adults
4.3.1. Adults Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)
4.4. Pediatrics
4.4.1. Pediatrics Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)
Chapter 5. Oral Clinical Nutrition Market: Indication Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Oral Clinical Nutrition Market: Stage Movement Analysis, USD Million, 2022 & 2030
5.3. Alzheimer’s
5.3.1. Alzheimer’s Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)
5.4. Nutrition Deficiency
5.4.1. Nutrition Deficiency Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)
5.5. Cancer Care
5.5.1. Cancer Care Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)
5.6. Diabetes
5.6.1. Diabetes Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)
5.7. Chronic Kidney Diseases
5.7.1. Chronic Kidney Diseases Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)
5.8. Orphan Diseases
5.8.1. Orphan Diseases Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)
5.9. Dysphagia
5.9.1. Dysphagia Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)
5.10. Pain Management
5.10.1. Pain Management Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)
5.11. Malabsorption/GI Disorder/Diarrhea
5.11.1. Malabsorption/GI Disorder/Diarrhea Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)
5.12. Others
5.12.1. Others Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)
Chapter 6. Oral Clinical Nutrition Market: Sales Channel Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Oral Clinical Nutrition Market: Sales Channel Movement Analysis, USD Million, 2022 & 2030
6.3. Online Sales
6.3.1. Online Sales Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)
6.4. Retail Sales
6.4.1. Retail Sales Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)
6.5. Institutional Sales
6.5.1. Institutional Sales Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)
Chapter 7. Oral Clinical Nutrition Market: Regional Estimates & Trend Analysis
7.1. Oral Clinical Nutrition Market Share, By Region, 2022 & 2030, USD Million
7.2. North America
7.2.1. North America Oral Clinical Nutrition Market estimates and forecasts, 2018 – 2030 (USD Million)
7.2.2. U.S.
7.2.2.1. U.S. Oral Clinical Nutrition Market estimates and forecasts, 2018 – 2030 (USD Million)
7.2.3. Canada
7.2.3.1. Canada Oral Clinical Nutrition Market estimates and forecasts, 2018 – 2030 (USD Million)
7.3. Europe
7.3.1. Europe Oral Clinical Nutrition Market estimates and forecasts, 2018 – 2030 (USD Million)
7.3.2. U.K.
7.3.2.1. U.K. Oral Clinical Nutrition Market estimates and forecasts, 2018 – 2030 (USD Million)
7.3.3. Germany
7.3.3.1. Germany Oral Clinical Nutrition Market estimates and forecasts, 2018 – 2030 (USD Million)
7.3.4. France
7.3.4.1. France Oral Clinical Nutrition Market estimates and forecasts, 2018 – 2030 (USD Million)
7.3.5. Italy
7.3.5.1. Italy Oral Clinical Nutrition Market estimates and forecasts, 2018 – 2030 (USD Million)
7.3.6. Spain
7.3.6.1. Spain Oral Clinical Nutrition Market estimates and forecasts, 2018 – 2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Denmark Oral Clinical Nutrition Market estimates and forecasts, 2018 – 2030 (USD Million)
7.3.8. Norway
7.3.8.1. Norway Oral Clinical Nutrition Market estimates and forecasts, 2018 – 2030 (USD Million)
7.3.9. Sweden
7.3.9.1. Sweden Oral Clinical Nutrition Market estimates and forecasts, 2018 – 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Oral Clinical Nutrition Market estimates and forecasts, 2018 – 2030 (USD Million)
7.4.2. China
7.4.2.1. China Oral Clinical Nutrition Market estimates and forecasts, 2018 – 2030 (USD Million)
7.4.3. Japan
7.4.3.1. Japan Oral Clinical Nutrition Market estimates and forecasts, 2018 – 2030 (USD Million)
7.4.4. India
7.4.4.1. India Oral Clinical Nutrition Market estimates and forecasts, 2018 – 2030 (USD Million)
7.4.5. Thailand
7.4.5.1. Thailand Oral Clinical Nutrition Market estimates and forecasts, 2018 – 2030 (USD Million)
7.4.6. South Korea
7.4.6.1. South Korea Oral Clinical Nutrition Market estimates and forecasts, 2018 – 2030 (USD Million)
7.4.7. Australia
7.4.7.1. Australia Oral Clinical Nutrition Market estimates and forecasts, 2018 – 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Oral Clinical Nutrition Market estimates and forecasts, 2018 – 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Brazil Oral Clinical Nutrition Market estimates and forecasts, 2018 – 2030 (USD Million)
7.5.3. Mexico
7.5.3.1. Mexico Oral Clinical Nutrition Market estimates and forecasts, 2018 – 2030 (USD Million)
7.5.4. Argentina
7.5.4.1. Argentina Oral Clinical Nutrition Market estimates and forecasts, 2018 – 2030 (USD Million)
7.6. Middle East and Africa
7.6.1. Middle East and Africa Oral Clinical Nutrition Market estimates and forecasts, 2018 – 2030 (USD Million)
7.6.2. South Africa
7.6.2.1. South Africa Oral Clinical Nutrition Market estimates and forecasts, 2018 – 2030 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1. Saudi Arabia Oral Clinical Nutrition Market estimates and forecasts, 2018 – 2030 (USD Million)
7.6.4. UAE
7.6.4.1. UAE Oral Clinical Nutrition Market estimates and forecasts, 2018 – 2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. Kuwait Oral Clinical Nutrition Market estimates and forecasts, 2018 – 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Overview
8.2. Financial Analysis
8.3. Product Benchmarking
8.4. Strategy Mapping
8.4.1. Product Launch
8.4.2. Acquisition
8.4.3. Collaboration
8.5. Recent Developments & Impact Analysis, by Key Market Participants
8.6. Company/Competition Categorization
8.7. List of key emerging companies/technology disruptors/innovators
8.8. Company Market Position Analysis
|
| ※본 조사보고서 [세계의 경구용 임상 영양 시장 (2023~2030) : 성인, 소아] (코드 : GRV23MR128) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 경구용 임상 영양 시장 (2023~2030) : 성인, 소아] 에 대해서 E메일 문의는 여기를 클릭하세요. |
※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!
